Germany’s Merck is investing €35 million in biosafety testing at its Glasgow and Stirling sites in Scotland. When completed – no date has been given – the company said...
In what it calls another major step toward implementing its sustainability strategy, Germany’s Merck has signed a 16-year, off-site, virtual power purchase agreement...
Germany’s Merck said this week it has signed a non-binding Memorandum of Understanding (MoU) with South Korea’s Ministry of Trade, Industry and Energy (MOTIE), and...
India-headquartered drugmaker Glenmark is said to be taking another look at selling a majority stake in its business with active pharmaceutical ingredients (APIs), which...
As April winds down and major German chemical companies hold their annual shareholder meetings, questions are being asked whether about the country is tying its trade too...
Shares of Prometheus Biosciences soared on news that US drugs major Merck will acquire the company in an all-cash deal valued at roughly $200 per share, or $10.8 billion...
Germany’s Merck plans to invest some €300 million in an integrated specialty gas plant in Hometown, Pennsylvania, to support the development of its semiconductor business...
Germany’s Merck will regain exclusive worldwide rights to develop, manufacture and commercialize the anti-programmed death ligand-1 (PD-L1) antibody Bavencio (avelumab)...
